<html xmlns:v="urn:schemas-microsoft-com:vml"
xmlns:o="urn:schemas-microsoft-com:office:office"
xmlns:w="urn:schemas-microsoft-com:office:word"
xmlns:m="http://schemas.microsoft.com/office/2004/12/omml"
xmlns:mv="http://macVmlSchemaUri" xmlns="http://www.w3.org/TR/REC-html40">

<head>
<meta name=Title content="">
<meta name=Keywords content="">
<meta http-equiv=Content-Type content="text/html; charset=utf-8">
<meta name=ProgId content=Word.Document>
<meta name=Generator content="Microsoft Word 14">
<meta name=Originator content="Microsoft Word 14">
<link rel=File-List href="OP_S8_files/filelist.xml">
<link rel=Edit-Time-Data href="OP_S8_files/editdata.mso">
<!--[if !mso]>
<style>
v\:* {behavior:url(#default#VML);}
o\:* {behavior:url(#default#VML);}
w\:* {behavior:url(#default#VML);}
.shape {behavior:url(#default#VML);}
</style>
<![endif]--><!--[if gte mso 9]><xml>
 <o:DocumentProperties>
  <o:Author>Bruno Gonçalves</o:Author>
  <o:LastAuthor>Bruno Gonçalves</o:LastAuthor>
  <o:Revision>1</o:Revision>
  <o:TotalTime>1</o:TotalTime>
  <o:Created>2016-03-08T21:45:00Z</o:Created>
  <o:LastSaved>2016-03-08T21:46:00Z</o:LastSaved>
  <o:Pages>6</o:Pages>
  <o:Words>2869</o:Words>
  <o:Characters>16359</o:Characters>
  <o:Company>IMM</o:Company>
  <o:Lines>136</o:Lines>
  <o:Paragraphs>38</o:Paragraphs>
  <o:CharactersWithSpaces>19190</o:CharactersWithSpaces>
  <o:Version>14.0</o:Version>
 </o:DocumentProperties>
 <o:OfficeDocumentSettings>
  <o:AllowPNG/>
 </o:OfficeDocumentSettings>
</xml><![endif]-->
<link rel=themeData href="OP_S8_files/themedata.xml">
<!--[if gte mso 9]><xml>
 <w:WordDocument>
  <w:TrackMoves>false</w:TrackMoves>
  <w:TrackFormatting/>
  <w:PunctuationKerning/>
  <w:ValidateAgainstSchemas/>
  <w:SaveIfXMLInvalid>false</w:SaveIfXMLInvalid>
  <w:IgnoreMixedContent>false</w:IgnoreMixedContent>
  <w:AlwaysShowPlaceholderText>false</w:AlwaysShowPlaceholderText>
  <w:DoNotPromoteQF/>
  <w:LidThemeOther>EN-US</w:LidThemeOther>
  <w:LidThemeAsian>JA</w:LidThemeAsian>
  <w:LidThemeComplexScript>X-NONE</w:LidThemeComplexScript>
  <w:Compatibility>
   <w:BreakWrappedTables/>
   <w:SnapToGridInCell/>
   <w:WrapTextWithPunct/>
   <w:UseAsianBreakRules/>
   <w:DontGrowAutofit/>
   <w:SplitPgBreakAndParaMark/>
   <w:EnableOpenTypeKerning/>
   <w:DontFlipMirrorIndents/>
   <w:OverrideTableStyleHps/>
   <w:UseFELayout/>
  </w:Compatibility>
  <m:mathPr>
   <m:mathFont m:val="Cambria Math"/>
   <m:brkBin m:val="before"/>
   <m:brkBinSub m:val="&#45;-"/>
   <m:smallFrac m:val="off"/>
   <m:dispDef/>
   <m:lMargin m:val="0"/>
   <m:rMargin m:val="0"/>
   <m:defJc m:val="centerGroup"/>
   <m:wrapIndent m:val="1440"/>
   <m:intLim m:val="subSup"/>
   <m:naryLim m:val="undOvr"/>
  </m:mathPr></w:WordDocument>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <w:LatentStyles DefLockedState="false" DefUnhideWhenUsed="true"
  DefSemiHidden="true" DefQFormat="false" DefPriority="99"
  LatentStyleCount="276">
  <w:LsdException Locked="false" Priority="0" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Normal"/>
  <w:LsdException Locked="false" Priority="9" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="heading 1"/>
  <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 2"/>
  <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 3"/>
  <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 4"/>
  <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 5"/>
  <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 6"/>
  <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 7"/>
  <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 8"/>
  <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 9"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 1"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 2"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 3"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 4"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 5"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 6"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 7"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 8"/>
  <w:LsdException Locked="false" Priority="39" Name="toc 9"/>
  <w:LsdException Locked="false" Priority="35" QFormat="true" Name="caption"/>
  <w:LsdException Locked="false" Priority="10" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Title"/>
  <w:LsdException Locked="false" Priority="1" Name="Default Paragraph Font"/>
  <w:LsdException Locked="false" Priority="11" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Subtitle"/>
  <w:LsdException Locked="false" Priority="22" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Strong"/>
  <w:LsdException Locked="false" Priority="20" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Emphasis"/>
  <w:LsdException Locked="false" Priority="59" SemiHidden="false"
   UnhideWhenUsed="false" Name="Table Grid"/>
  <w:LsdException Locked="false" UnhideWhenUsed="false" Name="Placeholder Text"/>
  <w:LsdException Locked="false" Priority="1" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="No Spacing"/>
  <w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading"/>
  <w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List"/>
  <w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid"/>
  <w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1"/>
  <w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2"/>
  <w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1"/>
  <w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2"/>
  <w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1"/>
  <w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2"/>
  <w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3"/>
  <w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List"/>
  <w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading"/>
  <w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List"/>
  <w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid"/>
  <w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading Accent 1"/>
  <w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List Accent 1"/>
  <w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid Accent 1"/>
  <w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1 Accent 1"/>
  <w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2 Accent 1"/>
  <w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1 Accent 1"/>
  <w:LsdException Locked="false" UnhideWhenUsed="false" Name="Revision"/>
  <w:LsdException Locked="false" Priority="34" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="List Paragraph"/>
  <w:LsdException Locked="false" Priority="29" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Quote"/>
  <w:LsdException Locked="false" Priority="30" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Intense Quote"/>
  <w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2 Accent 1"/>
  <w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1 Accent 1"/>
  <w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2 Accent 1"/>
  <w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3 Accent 1"/>
  <w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List Accent 1"/>
  <w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading Accent 1"/>
  <w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List Accent 1"/>
  <w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid Accent 1"/>
  <w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading Accent 2"/>
  <w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List Accent 2"/>
  <w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid Accent 2"/>
  <w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1 Accent 2"/>
  <w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2 Accent 2"/>
  <w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1 Accent 2"/>
  <w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2 Accent 2"/>
  <w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1 Accent 2"/>
  <w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2 Accent 2"/>
  <w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3 Accent 2"/>
  <w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List Accent 2"/>
  <w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading Accent 2"/>
  <w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List Accent 2"/>
  <w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid Accent 2"/>
  <w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading Accent 3"/>
  <w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List Accent 3"/>
  <w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid Accent 3"/>
  <w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1 Accent 3"/>
  <w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2 Accent 3"/>
  <w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1 Accent 3"/>
  <w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2 Accent 3"/>
  <w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1 Accent 3"/>
  <w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2 Accent 3"/>
  <w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3 Accent 3"/>
  <w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List Accent 3"/>
  <w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading Accent 3"/>
  <w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List Accent 3"/>
  <w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid Accent 3"/>
  <w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading Accent 4"/>
  <w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List Accent 4"/>
  <w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid Accent 4"/>
  <w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1 Accent 4"/>
  <w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2 Accent 4"/>
  <w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1 Accent 4"/>
  <w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2 Accent 4"/>
  <w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1 Accent 4"/>
  <w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2 Accent 4"/>
  <w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3 Accent 4"/>
  <w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List Accent 4"/>
  <w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading Accent 4"/>
  <w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List Accent 4"/>
  <w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid Accent 4"/>
  <w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading Accent 5"/>
  <w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List Accent 5"/>
  <w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid Accent 5"/>
  <w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1 Accent 5"/>
  <w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2 Accent 5"/>
  <w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1 Accent 5"/>
  <w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2 Accent 5"/>
  <w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1 Accent 5"/>
  <w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2 Accent 5"/>
  <w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3 Accent 5"/>
  <w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List Accent 5"/>
  <w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading Accent 5"/>
  <w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List Accent 5"/>
  <w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid Accent 5"/>
  <w:LsdException Locked="false" Priority="60" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Shading Accent 6"/>
  <w:LsdException Locked="false" Priority="61" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light List Accent 6"/>
  <w:LsdException Locked="false" Priority="62" SemiHidden="false"
   UnhideWhenUsed="false" Name="Light Grid Accent 6"/>
  <w:LsdException Locked="false" Priority="63" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 1 Accent 6"/>
  <w:LsdException Locked="false" Priority="64" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Shading 2 Accent 6"/>
  <w:LsdException Locked="false" Priority="65" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 1 Accent 6"/>
  <w:LsdException Locked="false" Priority="66" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium List 2 Accent 6"/>
  <w:LsdException Locked="false" Priority="67" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 1 Accent 6"/>
  <w:LsdException Locked="false" Priority="68" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 2 Accent 6"/>
  <w:LsdException Locked="false" Priority="69" SemiHidden="false"
   UnhideWhenUsed="false" Name="Medium Grid 3 Accent 6"/>
  <w:LsdException Locked="false" Priority="70" SemiHidden="false"
   UnhideWhenUsed="false" Name="Dark List Accent 6"/>
  <w:LsdException Locked="false" Priority="71" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Shading Accent 6"/>
  <w:LsdException Locked="false" Priority="72" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful List Accent 6"/>
  <w:LsdException Locked="false" Priority="73" SemiHidden="false"
   UnhideWhenUsed="false" Name="Colorful Grid Accent 6"/>
  <w:LsdException Locked="false" Priority="19" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Subtle Emphasis"/>
  <w:LsdException Locked="false" Priority="21" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Intense Emphasis"/>
  <w:LsdException Locked="false" Priority="31" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Subtle Reference"/>
  <w:LsdException Locked="false" Priority="32" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Intense Reference"/>
  <w:LsdException Locked="false" Priority="33" SemiHidden="false"
   UnhideWhenUsed="false" QFormat="true" Name="Book Title"/>
  <w:LsdException Locked="false" Priority="37" Name="Bibliography"/>
  <w:LsdException Locked="false" Priority="39" QFormat="true" Name="TOC Heading"/>
 </w:LatentStyles>
</xml><![endif]-->
<style>
<!--
 /* Font Definitions */
@font-face
	{font-family:Arial;
	panose-1:2 11 6 4 2 2 2 2 2 4;
	mso-font-charset:0;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-536859905 -1073711037 9 0 511 0;}
@font-face
	{font-family:Arial;
	panose-1:2 11 6 4 2 2 2 2 2 4;
	mso-font-charset:0;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-536859905 -1073711037 9 0 511 0;}
@font-face
	{font-family:Cambria;
	panose-1:2 4 5 3 5 4 6 3 2 4;
	mso-font-charset:0;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-536870145 1073743103 0 0 415 0;}
@font-face
	{font-family:"Lucida Grande";
	panose-1:2 11 6 0 4 5 2 2 2 4;
	mso-font-charset:0;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-520090897 1342218751 0 0 447 0;}
 /* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
	{mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-parent:"";
	margin:0cm;
	margin-bottom:.0001pt;
	text-align:justify;
	text-justify:inter-ideograph;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	mso-bidi-font-size:11.0pt;
	font-family:Arial;
	mso-fareast-font-family:Cambria;
	mso-fareast-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;
	mso-ansi-language:DE-CH;}
p.MsoAcetate, li.MsoAcetate, div.MsoAcetate
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-link:"Balloon Text Char";
	margin:0cm;
	margin-bottom:.0001pt;
	text-align:justify;
	text-justify:inter-ideograph;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:"Lucida Grande";
	mso-fareast-font-family:Cambria;
	mso-fareast-theme-font:minor-latin;
	mso-ansi-language:DE-CH;}
span.BalloonTextChar
	{mso-style-name:"Balloon Text Char";
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"Balloon Text";
	mso-ansi-font-size:9.0pt;
	mso-bidi-font-size:9.0pt;
	font-family:"Lucida Grande";
	mso-ascii-font-family:"Lucida Grande";
	mso-fareast-font-family:Cambria;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:"Lucida Grande";
	mso-bidi-font-family:"Lucida Grande";
	mso-ansi-language:DE-CH;}
.MsoChpDefault
	{mso-style-type:export-only;
	mso-default-props:yes;
	font-family:Cambria;
	mso-ascii-font-family:Cambria;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:"ＭＳ 明朝";
	mso-fareast-theme-font:minor-fareast;
	mso-hansi-font-family:Cambria;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;}
@page WordSection1
	{size:595.0pt 842.0pt;
	margin:72.0pt 89.85pt 72.0pt 89.85pt;
	mso-header-margin:35.45pt;
	mso-footer-margin:35.45pt;
	mso-paper-source:0;}
div.WordSection1
	{page:WordSection1;}
-->
</style>
<!--[if gte mso 10]>
<style>
 /* Style Definitions */
table.MsoNormalTable
	{mso-style-name:"Table Normal";
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-parent:"";
	mso-padding-alt:0cm 5.4pt 0cm 5.4pt;
	mso-para-margin:0cm;
	mso-para-margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:Cambria;
	mso-ascii-font-family:Cambria;
	mso-ascii-theme-font:minor-latin;
	mso-hansi-font-family:Cambria;
	mso-hansi-theme-font:minor-latin;}
</style>
<![endif]-->
</head>

<body bgcolor=white lang=EN-US style='tab-interval:36.0pt'>

<div class=WordSection1>

<p class=MsoNormal><b style='mso-bidi-font-weight:normal'><span
style='mso-bidi-font-size:9.0pt;mso-fareast-font-family:"Times New Roman";
mso-bidi-font-family:Arial;mso-ansi-language:EN-US;mso-fareast-language:PT'>OP27
- Trace And Control The Regional Expansion Of Extended-Spectrum Β-Lactamase
Producing ST15 <i style='mso-bidi-font-style:normal'>Klebsiella pneumoniae</i><span
style='text-transform:uppercase'><o:p></o:p></span></span></b></p>

<p class=MsoNormal><u><span style='mso-bidi-font-size:9.0pt;mso-fareast-font-family:
"Times New Roman";mso-bidi-font-family:Arial;color:black;mso-ansi-language:
EN-US;mso-fareast-language:PT'>John W. A. Rossen</span></u><sup><span
style='mso-bidi-font-size:9.0pt;mso-fareast-font-family:"Times New Roman";
mso-bidi-font-family:Arial;color:black;mso-ansi-language:EN-US;mso-fareast-language:
PT'>1</span></sup><span style='mso-bidi-font-size:9.0pt;mso-fareast-font-family:
"Times New Roman";mso-bidi-font-family:Arial;color:black;mso-ansi-language:
EN-US;mso-fareast-language:PT'>; Mariette Lokate<sup>1</sup>; Ruud H.
Deurenberg<sup>1</sup>; Marga Tepper<sup>1</sup>; Jan P. Arends<sup>1</sup>;
Erwin G. C. Raangs<sup>1</sup>; Jerome Lo-Ten-Foe<sup>1</sup>; Hajo Grundmann<sup>1</sup>;
Kai Zhou<sup>1</sup>; Alexander W. Friedrich<sup>1</sup><o:p></o:p></span></p>

<p class=MsoNormal><i style='mso-bidi-font-style:normal'><sup><span
style='mso-bidi-font-size:9.0pt;mso-fareast-font-family:"Times New Roman";
mso-bidi-font-family:Arial;color:black;mso-ansi-language:EN-US;mso-fareast-language:
PT'>1</span></sup></i><i style='mso-bidi-font-style:normal'><span
style='mso-bidi-font-size:9.0pt;mso-fareast-font-family:"Times New Roman";
mso-bidi-font-family:Arial;color:black;mso-ansi-language:EN-US;mso-fareast-language:
PT'>University of Groningen, University Medical Center Groningen<o:p></o:p></span></i></p>

<p class=MsoNormal><span style='mso-bidi-font-family:Arial;color:black;
mso-themecolor:text1;mso-ansi-language:EN-US'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:6.0pt'><b><span lang=EN-GB
style='font-size:8.0pt;mso-fareast-font-family:"Times New Roman";mso-bidi-font-family:
Arial;color:black;mso-ansi-language:EN-GB;mso-fareast-language:PT'>Background: </span></b><i><span
lang=EN-GB style='font-size:8.0pt;mso-fareast-font-family:"Times New Roman";
mso-bidi-font-family:Arial;color:black;mso-ansi-language:EN-GB;mso-fareast-language:
PT'>Klebsiella pneumoniae</span></i><span lang=EN-GB style='font-size:8.0pt;
mso-fareast-font-family:"Times New Roman";mso-bidi-font-family:Arial;
color:black;mso-ansi-language:EN-GB;mso-fareast-language:PT'> has emerged as an
important nosocomial pathogen, known as one of the “ESKAPE” pathogens.
Especially, the prevalence of multi-drug resistance <i>K. pneumoniae</i>
increased dramatically in recent years. This limits efficient clinical
treatment tremendously resulting in undesirable treatment outcomes. In this
study, we present our experience in using whole-genome sequencing (WGS) and
further developing an outbreak clone-specific PCR for tracing and controlling a
regional and inter-institutional outbreak caused by a ST15 CTX-M-15-KP clone
between May 2012 and September 2013 in the north of Netherlands.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:6.0pt'><b><span lang=EN-GB
style='font-size:8.0pt;mso-fareast-font-family:"Times New Roman";mso-bidi-font-family:
Arial;color:black;mso-ansi-language:EN-GB;mso-fareast-language:PT'>Materials |
Methods: </span></b><span lang=EN-GB style='font-size:8.0pt;mso-fareast-font-family:
"Times New Roman";mso-bidi-font-family:Arial;color:black;mso-ansi-language:
EN-GB;mso-fareast-language:PT'>In total, 19 <i>K. pneumoniae</i> isolates
obtained from patients and environment were included. Genomes were manually
curated after performing automatic annotation on the RAST server. Acquired
antimicrobial resistance genes were identified by uploading assembled genomes
to the Resfinder server. Other genes relating to resistance and virulence were
detected using the mapping unit of CLC Genomics Workbench to map and/or blast
assembled genomes to a pseudomolecule generated by concatenating a set of
target genes. SNPs were detected using CLC Genomics Workbench by mapping
genomes to the finished genome of <i>K. pneumoniae</i> PMK1. High-quality SNPs
were used for SNP-based phylogenetic reconstruction by RAxML v7.4.2. Assembled
genomes and genomes retrieved from GenBank were aligned by ProgressiveMauve.
Fragments (≥500 bp) shared by all genomes were collected and concatenated
resulting in a pseudomolecule defined as the core genome. Alignment of core
genomes was used for estimating the maximum likelihood (ML) phylogeny by RAxML
v7.4.2. The core genome of outbreak isolates was blasted against our local <i>K.
pneumoniae</i> genome database (76 genomes with diverse sequence types). The
unique fragments were extracted and blasted against GenBank. The non-match
fragments not related to mobile genetic elements (e.g. phages, plasmids, and
transposons) were considered as the DNA signatures for the outbreak clone.
Primers for multiplex PCR specific to DNA signatures were designed by MPprimer.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:6.0pt'><b><span lang=EN-GB
style='font-size:8.0pt;mso-fareast-font-family:"Times New Roman";mso-bidi-font-family:
Arial;color:black;mso-ansi-language:EN-GB;mso-fareast-language:PT'>Results: </span></b><span
lang=EN-GB style='font-size:8.0pt;mso-fareast-font-family:"Times New Roman";
mso-bidi-font-family:Arial;color:black;mso-ansi-language:EN-GB;mso-fareast-language:
PT'>A suspected epidemiological link between clinical <i>K. pneumoniae</i>
isolates was supported by patient contact tracing and genomic phylogenetic
analysis from May to November 2012. By May 2013, a patient treated in three
institutions in two cities was involved in an expanding cluster caused by this
high-risk clone (HiRiC) (local expansion, CTX-M-15 producing, and containing
hypervirulence factors). A clone-specific multiplex PCR was developed for patient
screening by which another patient was identified in September 2013. Genomic
phylogenetic analysis resolved a close homology with isolates previously found
in the USA, and split ST15 strains into two clades. Two serotypes (K24 and K60)
were carried by the two clades, respectively. Environmental contamination and
lack of consistent patient screening were identified as being responsible for
the clone dissemination.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:6.0pt'><b><span lang=EN-GB
style='font-size:8.0pt;mso-fareast-font-family:"Times New Roman";mso-bidi-font-family:
Arial;color:black;mso-ansi-language:EN-GB;mso-fareast-language:PT'>Conclusion</span></b><b
style='mso-bidi-font-weight:normal'><span lang=EN-GB style='font-size:8.0pt;
mso-fareast-font-family:"Times New Roman";mso-bidi-font-family:Arial;
color:black;mso-ansi-language:EN-GB;mso-fareast-language:PT'>:</span></b><span
lang=EN-GB style='font-size:8.0pt;mso-fareast-font-family:"Times New Roman";
mso-bidi-font-family:Arial;color:black;mso-ansi-language:EN-GB;mso-fareast-language:
PT'> The investigation addresses the advantages of WGS in the early detection
of HiRiC with a high propensity of nosocomial transmission and prolonged
circulation in the regional patient population. It shows the added value of
designing a clone-specific multiplex PCR for effective and adequate infection
control management. Our study suggests the necessity for
inter-institutional/regional collaboration for infection/outbreak management of
<i>K. pneumoniae</i> HiRiCs.<o:p></o:p></span></p>

<span lang=EN-GB style='font-size:8.0pt;line-height:115%;font-family:Arial;
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:EN-GB;
mso-fareast-language:PT;mso-bidi-language:AR-SA'><br clear=all
style='mso-special-character:line-break;page-break-before:always'>
</span>

<p class=MsoNormal align=left style='margin-bottom:10.0pt;text-align:left;
line-height:115%'><span lang=EN-GB style='font-size:8.0pt;line-height:115%;
mso-fareast-font-family:"Times New Roman";mso-bidi-font-family:Arial;
color:black;mso-ansi-language:EN-GB;mso-fareast-language:PT'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal><b style='mso-bidi-font-weight:normal'><span
style='mso-bidi-font-size:9.0pt;mso-fareast-font-family:"Times New Roman";
mso-bidi-font-family:Arial;mso-ansi-language:EN-US;mso-fareast-language:PT'>OP28
- Identification Of Multiple Silent Introductions And Household Transmission Of
Methicillin-Resistant <i style='mso-bidi-font-style:normal'>Staphylococcus
aureus</i> USA300 In The United Kingdom<span style='text-transform:uppercase'><o:p></o:p></span></span></b></p>

<p class=MsoNormal><u><span style='mso-bidi-font-size:9.0pt;mso-fareast-font-family:
"Times New Roman";mso-bidi-font-family:Arial;color:black;mso-ansi-language:
EN-US;mso-fareast-language:PT'>Michelle S. Toleman</span></u><sup><span
style='mso-bidi-font-size:9.0pt;mso-fareast-font-family:"Times New Roman";
mso-bidi-font-family:Arial;color:black;mso-ansi-language:EN-US;mso-fareast-language:
PT'>1</span></sup><span style='mso-bidi-font-size:9.0pt;mso-fareast-font-family:
"Times New Roman";mso-bidi-font-family:Arial;color:black;mso-ansi-language:
EN-US;mso-fareast-language:PT'>; Sandra Reuter<sup>1</sup>; Francesc Coll<sup>1</sup>;
Ewan Harrison<sup>1</sup>; Estee Torok<sup>1</sup>; Nicholas Brown<sup>1</sup>;
Beth Blane<sup>1</sup>; Julian Parkhill<sup>2</sup>; Sharon Peacock<sup>3</sup><o:p></o:p></span></p>

<p class=MsoNormal><i style='mso-bidi-font-style:normal'><sup><span
style='mso-bidi-font-size:9.0pt;mso-fareast-font-family:"Times New Roman";
mso-bidi-font-family:Arial;color:black;mso-ansi-language:EN-US;mso-fareast-language:
PT'>1</span></sup></i><i style='mso-bidi-font-style:normal'><span
style='mso-bidi-font-size:9.0pt;mso-fareast-font-family:"Times New Roman";
mso-bidi-font-family:Arial;color:black;mso-ansi-language:EN-US;mso-fareast-language:
PT'>University of Cambridge; <sup>2</sup>Sanger Insitute; <sup>3</sup>London
School of Hygiene and Tropical Medicine<o:p></o:p></span></i></p>

<p class=MsoNormal><span style='mso-bidi-font-family:Arial;color:black;
mso-themecolor:text1;mso-ansi-language:EN-US'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:6.0pt'><b><span lang=EN-GB
style='font-size:8.0pt;mso-fareast-font-family:"Times New Roman";mso-bidi-font-family:
Arial;color:black;mso-ansi-language:EN-GB;mso-fareast-language:PT'>Background: </span></b><span
lang=EN-GB style='font-size:8.0pt;mso-fareast-font-family:"Times New Roman";
mso-bidi-font-family:Arial;color:black;mso-ansi-language:EN-GB;mso-fareast-language:
PT'>The USA300 MRSA clone is widely disseminated across the United States
(USA).This contrasts sharply with Europe, where only sporadic cases or small outbreaks
have been described. The prevalence of USA300 in the United Kingdom is unknown.
We conducted prospective surveillance for USA300 in the East of England.<b><o:p></o:p></b></span></p>

<p class=MsoNormal style='margin-bottom:6.0pt'><b><span lang=EN-GB
style='font-size:8.0pt;mso-fareast-font-family:"Times New Roman";mso-bidi-font-family:
Arial;color:black;mso-ansi-language:EN-GB;mso-fareast-language:PT'>Methods: </span></b><span
lang=EN-GB style='font-size:8.0pt;mso-fareast-font-family:"Times New Roman";
mso-bidi-font-family:Arial;color:black;mso-ansi-language:EN-GB;mso-fareast-language:
PT'>A one-year prospective cohort study was performed between 2012 and 2013,
where all cases with MRSA isolated in the microbiology laboratory at a tertiary
care hospital in the east of England were identified and at least one MRSA
isolate from each case whole-genome sequenced. This captured hospital and
community healthcare isolates. Epidemiological and clinical information was
collected on each case. Phylogenetic reconstruction of the collection was
performed and compared to USA300 genomes from the USA.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:6.0pt'><b><span lang=EN-GB
style='font-size:8.0pt;mso-fareast-font-family:"Times New Roman";mso-bidi-font-family:
Arial;color:black;mso-ansi-language:EN-GB;mso-fareast-language:PT'>Results: </span></b><span
lang=EN-GB style='font-size:8.0pt;mso-fareast-font-family:"Times New Roman";
mso-bidi-font-family:Arial;color:black;mso-ansi-language:EN-GB;mso-fareast-language:
PT'>We processed samples from 1489 patients and sequenced 2307 isolates
associated with carriage and/or disease. The USA300 MRSA clone was isolated
from 1.6% (n=24) of cases. The majority of first positive samples were
submitted from first-opinion services (emergency department (8/24, 33%),
general practitioners (5/24, 21%)). Half of the cases had USA300 isolated from
carriage screens alone, while 10 cases had skin and soft tissue infection and
two cases had invasive infection. Cases were distributed throughout the
12-month period. Phylogenetic analyses identified multiple separate introductions
and household transmission of USA300.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:6.0pt'><b><span lang=EN-GB
style='font-size:8.0pt;mso-fareast-font-family:"Times New Roman";mso-bidi-font-family:
Arial;color:black;mso-ansi-language:EN-GB;mso-fareast-language:PT'>Conclusions:
</span></b><span lang=EN-GB style='font-size:8.0pt;mso-fareast-font-family:
"Times New Roman";mso-bidi-font-family:Arial;color:black;mso-ansi-language:
EN-GB;mso-fareast-language:PT'>This provides evidence that USA300 was
repeatedly introduced into the East of England in 2012-13. Clinical and
epidemiological investigation revealed the same characteristics as the US
epidemic (household transmissions and a high proportion of skin and soft tissue
infection). In the absence of systematic surveillance, we may miss the
emergence of novel endemic MRSA lineages in England.<o:p></o:p></span></p>

<span lang=EN-GB style='font-size:8.0pt;line-height:115%;font-family:Arial;
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:EN-GB;
mso-fareast-language:PT;mso-bidi-language:AR-SA'><br clear=all
style='mso-special-character:line-break;page-break-before:always'>
</span>

<p class=MsoNormal align=left style='margin-bottom:10.0pt;text-align:left;
line-height:115%'><span lang=EN-GB style='font-size:8.0pt;line-height:115%;
mso-fareast-font-family:"Times New Roman";mso-bidi-font-family:Arial;
color:black;mso-ansi-language:EN-GB;mso-fareast-language:PT'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal><b style='mso-bidi-font-weight:normal'><span
style='mso-bidi-font-size:9.0pt;mso-fareast-font-family:"Times New Roman";
mso-bidi-font-family:Arial;mso-ansi-language:EN-US;mso-fareast-language:PT'>OP29
- Five Years Of Genomic Data From The Meningitis Research Foundation
Meningococcal Genome Library (MRF-MGL) – UK And Ireland 2010-2015<span
style='text-transform:uppercase'><o:p></o:p></span></span></b></p>

<p class=MsoNormal><u><span style='mso-bidi-font-size:9.0pt;mso-fareast-font-family:
"Times New Roman";mso-bidi-font-family:Arial;color:black;mso-ansi-language:
EN-US;mso-fareast-language:PT'>Charlene Rodrigues</span></u><sup><span
style='mso-bidi-font-size:9.0pt;mso-fareast-font-family:"Times New Roman";
mso-bidi-font-family:Arial;color:black;mso-ansi-language:EN-US;mso-fareast-language:
PT'>1</span></sup><span style='mso-bidi-font-size:9.0pt;mso-fareast-font-family:
"Times New Roman";mso-bidi-font-family:Arial;color:black;mso-ansi-language:
EN-US;mso-fareast-language:PT'>; Carina Brehony<sup>2</sup>; Richard Moxon<sup>1</sup>;
Martin Maiden<sup>1</sup><o:p></o:p></span></p>

<p class=MsoNormal><i style='mso-bidi-font-style:normal'><sup><span
style='mso-bidi-font-size:9.0pt;mso-fareast-font-family:"Times New Roman";
mso-bidi-font-family:Arial;color:black;mso-ansi-language:EN-US;mso-fareast-language:
PT'>1</span></sup></i><i style='mso-bidi-font-style:normal'><span
style='mso-bidi-font-size:9.0pt;mso-fareast-font-family:"Times New Roman";
mso-bidi-font-family:Arial;color:black;mso-ansi-language:EN-US;mso-fareast-language:
PT'>University of Oxford; <sup>2</sup>University Hospital Galway<o:p></o:p></span></i></p>

<p class=MsoNormal><span style='mso-bidi-font-family:Arial;color:black;
mso-themecolor:text1;mso-ansi-language:EN-US'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal><span lang=PT style='font-size:8.0pt;mso-fareast-font-family:
"Times New Roman";mso-bidi-font-family:Arial;color:black;mso-ansi-language:
PT;mso-fareast-language:PT'>Keywords</span><i><span lang=DE-CH
style='font-size:8.0pt;mso-fareast-font-family:"Times New Roman";mso-bidi-font-family:
Arial;color:black;mso-fareast-language:PT'>: Neisseria meningitidis</span></i><span
lang=DE-CH style='font-size:8.0pt;mso-fareast-font-family:"Times New Roman";
mso-bidi-font-family:Arial;color:black;mso-fareast-language:PT'>, meningococcal
disease, molecular epidemiology</span><b><span lang=PT style='font-size:8.0pt;
mso-fareast-font-family:"Times New Roman";mso-bidi-font-family:Arial;
color:black;mso-ansi-language:PT;mso-fareast-language:PT'><o:p></o:p></span></b></p>

<p class=MsoNormal><b><span lang=PT style='font-size:8.0pt;mso-fareast-font-family:
"Times New Roman";mso-bidi-font-family:Arial;color:black;mso-ansi-language:
PT;mso-fareast-language:PT'><o:p>&nbsp;</o:p></span></b></p>

<p class=MsoNormal style='margin-bottom:6.0pt'><b><span lang=EN-GB
style='font-size:8.0pt;mso-fareast-font-family:"Times New Roman";mso-bidi-font-family:
Arial;color:black;mso-ansi-language:EN-GB;mso-fareast-language:PT'>Background</span></b><b
style='mso-bidi-font-weight:normal'><span lang=EN-GB style='font-size:8.0pt;
mso-fareast-font-family:"Times New Roman";mso-bidi-font-family:Arial;
color:black;mso-ansi-language:EN-GB;mso-fareast-language:PT'>:</span></b><span
lang=EN-GB style='font-size:8.0pt;mso-fareast-font-family:"Times New Roman";
mso-bidi-font-family:Arial;color:black;mso-ansi-language:EN-GB;mso-fareast-language:
PT'> Invasive meningococcal disease (IMD) can manifest as either septicaemia,
meningitis or both with significant morbidity (20%) and mortality (3-10%).
Meningococcal conjugate serogroup C vaccines were implemented in the UK in 1999
and Ireland in 2000, resulting in a dramatic fall in incidence. Since then
there has been a declining but persistent disease burden, predominantly
serogroup B. The recent surge in serogroup W cases resulted in the introduction
of conjugate ACWY vaccine for teenagers in the UK, importantly MRF-MGL data
helping inform national vaccine policy. &nbsp;Multi-component protein vaccine
Bexsero® has also recently been implemented into the infant UK national
immunisation schedule (September 2015). With this rapidly changing landscape,
it is important to study population structure of&nbsp;<i>Neisseria meningitidis</i>&nbsp;using
whole genome sequencing methodology.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:6.0pt'><b><span lang=EN-GB
style='font-size:8.0pt;mso-fareast-font-family:"Times New Roman";mso-bidi-font-family:
Arial;color:black;mso-ansi-language:EN-GB;mso-fareast-language:PT'>Methods: </span></b><span
lang=EN-GB style='font-size:8.0pt;mso-fareast-font-family:"Times New Roman";
mso-bidi-font-family:Arial;color:black;mso-ansi-language:EN-GB;mso-fareast-language:
PT'>The MRF-MGL was developed by Public Health England, Scottish Haemophilus,
Legionella, Meningococcus and Pneumococcus Reference Laboratory, Wellcome
Sanger Institute and University of Oxford as a collaboration. The project is
funded by Meningitis Research Foundation. In addition we used the Irish Genome
Library (Epidemiology and Molecular Biology Unit and Irish Meningitis and
Meningococcal Reference Laboratory and University of Oxford).&nbsp; Genomic
data from IMD isolates from five epidemiological years, 2010-11 to 2014-15,
from UK and Republic of Ireland were studied. Analyses were performed using
embedded analysis tools and R version 3.2.2.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:6.0pt'><b><span lang=EN-GB
style='font-size:8.0pt;mso-fareast-font-family:"Times New Roman";mso-bidi-font-family:
Arial;color:black;mso-ansi-language:EN-GB;mso-fareast-language:PT'>Results: </span></b><span
lang=EN-GB style='font-size:8.0pt;mso-fareast-font-family:"Times New Roman";
mso-bidi-font-family:Arial;color:black;mso-ansi-language:EN-GB;mso-fareast-language:
PT'>Between 2010-11 and 2014-15 there were 2599 cases of culture-confirmed IMD
(UK n=2428, Ireland n=171) sequenced in the pubMLST database. Disease is
predominantly caused by serogroup B, though this was highest in 2010-11 (n=451)
with a progressive decline to 2014-15 (n=276). There was an increase in
serogroup W from 2010-11 (n=27) to 2014-15 (n=166). This increase was also seen
as a clonal expansion of ST-11/ET-37 clonal complex (cc) contributing to 30.6%
of all disease in 2014-15 compared to 3.8% in 2010-11 (Figure 1). Using
multilocus sequence typing (MLST), there were 84 different sequence types (ST)
in Ireland and 568 in UK. With higher resolution typing, ribosomal MLST (rST),
there were 108 rST in Ireland and 805 in the UK, but 2 rST containing 257 and
192 isolates each relating to ST-11/ET-37 complex (serogroup W) and ST-23
complex/Cluster A3 (serogroup Y) respectively. On analysis of vaccine antigens,
there were 569 different Bexsero® Antigen Sequence Typing (BAST)
profiles.&nbsp; No isolates had matches at 5 (BAST1) or 4 vaccine antigens.
There were 231 that matched BAST1 profile at 3 antigens (NHBA, PorA VR1 and
PorA VR2), 96.5% in ST-41/44 complex/lineage 3.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:6.0pt'><b><span lang=EN-GB
style='font-size:8.0pt;mso-fareast-font-family:"Times New Roman";mso-bidi-font-family:
Arial;color:black;mso-ansi-language:EN-GB;mso-fareast-language:PT'>Discussion: </span></b><span
lang=EN-GB style='font-size:8.0pt;mso-fareast-font-family:"Times New Roman";
mso-bidi-font-family:Arial;color:black;mso-ansi-language:EN-GB;mso-fareast-language:
PT'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:6.0pt'><span lang=EN-GB
style='font-size:8.0pt;mso-fareast-font-family:"Times New Roman";mso-bidi-font-family:
Arial;color:black;mso-ansi-language:EN-GB;mso-fareast-language:PT'>This unique
MRF-MGL, serves as a valuable resource for studying IMD in the UK and Ireland,
where vaccinations are likely to impact on&nbsp;<i>N. meningitidis</i>&nbsp;population.&nbsp;
Prior to both vaccines being introduced in autumn 2015, it is evident that
there is great diversity amongst all isolates, but only 9 cc make up the
majority of cases (90%). Serum bactericidal assays are the accepted correlate
of protection in IMD, and vaccine coverage has been estimated at 73%. However,
coverage of Bexsero® vaccine antigens is key, and in this cohort no isolates
matched at 4 or 5 loci, data that needs interpreting in conjunction with
Meningococcal Antigen Typing System assay outputs over coming months.<o:p></o:p></span></p>

<span lang=EN-GB style='font-size:8.0pt;line-height:115%;font-family:Arial;
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:EN-GB;
mso-fareast-language:PT;mso-bidi-language:AR-SA'><br clear=all
style='mso-special-character:line-break;page-break-before:always'>
</span>

<p class=MsoNormal align=left style='margin-bottom:10.0pt;text-align:left;
line-height:115%'><span lang=EN-GB style='font-size:8.0pt;line-height:115%;
mso-fareast-font-family:"Times New Roman";mso-bidi-font-family:Arial;
color:black;mso-ansi-language:EN-GB;mso-fareast-language:PT'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal><b style='mso-bidi-font-weight:normal'><span
style='mso-bidi-font-size:9.0pt;mso-fareast-font-family:"Times New Roman";
mso-bidi-font-family:Arial;mso-ansi-language:EN-US;mso-fareast-language:PT'>OP30
- Expansion Of Previously Circulating Clones Underlies The Replacement Of
Pneumococcal Serotypes In Adult IPD Following Introduction Of PCV7 In Portugal<span
style='text-transform:uppercase'><o:p></o:p></span></span></b></p>

<p class=MsoNormal><u><span lang=PT style='mso-bidi-font-size:9.0pt;mso-fareast-font-family:
"Times New Roman";mso-bidi-font-family:Arial;color:black;mso-ansi-language:
PT;mso-fareast-language:PT'>Andreia Neves Horácio</span></u><sup><span lang=PT
style='mso-bidi-font-size:9.0pt;mso-fareast-font-family:"Times New Roman";
mso-bidi-font-family:Arial;color:black;mso-ansi-language:PT;mso-fareast-language:
PT'>1</span></sup><span lang=PT style='mso-bidi-font-size:9.0pt;mso-fareast-font-family:
"Times New Roman";mso-bidi-font-family:Arial;color:black;mso-ansi-language:
PT;mso-fareast-language:PT'>; Catarina Silva Costa<sup>1</sup>; Jorge
Diamantino Miranda<sup>1</sup>; Joana Pimento Lopes<sup>1</sup>; Mário Ramirez<sup>1</sup>;
José Melo Cristino<sup>1</sup><o:p></o:p></span></p>

<p class=MsoNormal><i style='mso-bidi-font-style:normal'><sup><span lang=PT
style='mso-bidi-font-size:9.0pt;mso-fareast-font-family:"Times New Roman";
mso-bidi-font-family:Arial;color:black;mso-ansi-language:PT;mso-fareast-language:
PT'>1</span></sup></i><i style='mso-bidi-font-style:normal'><span lang=PT
style='mso-bidi-font-size:9.0pt;mso-fareast-font-family:"Times New Roman";
mso-bidi-font-family:Arial;color:black;mso-ansi-language:PT;mso-fareast-language:
PT'>Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de
Lisboa<o:p></o:p></span></i></p>

<p class=MsoNormal><span lang=PT style='mso-ansi-language:PT;mso-fareast-language:
PT'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:6.0pt'><b><span lang=EN-GB
style='font-size:8.0pt;mso-fareast-font-family:"Times New Roman";mso-bidi-font-family:
Arial;color:black;mso-ansi-language:EN-GB;mso-fareast-language:PT'>Background:&nbsp;</span></b><span
lang=EN-GB style='font-size:8.0pt;mso-fareast-font-family:"Times New Roman";
mso-bidi-font-family:Arial;color:black;mso-ansi-language:EN-GB;mso-fareast-language:
PT'>The 7-valent conjugate vaccine (PCV7) was available for children through
the private sector in Portugal from 2001 onwards until it was replaced in the
beginning of 2010 by the 13-valent conjugate vaccine (PCV13). In 2012, PCV13
received approval for use also in adults &gt; 50 years of age with an extension
being made to all ages in 2013. The aim of this study was to identify the
clones causing invasive pneumococcal disease (IPD) in adults between 2008 and
2011, a period when significant changes in serotypes have occurred and before
the availability of PCV13 for adults.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:6.0pt'><b><span lang=EN-GB
style='font-size:8.0pt;mso-fareast-font-family:"Times New Roman";mso-bidi-font-family:
Arial;color:black;mso-ansi-language:EN-GB;mso-fareast-language:PT'>Materials/Methods:</span></b><span
lang=EN-GB style='font-size:8.0pt;mso-fareast-font-family:"Times New Roman";
mso-bidi-font-family:Arial;color:black;mso-ansi-language:EN-GB;mso-fareast-language:
PT'> Among the 1660 isolates recovered from adult (&gt;=18 yrs) invasive
pneumococcal disease (IPD) in 2008-2011, a random sample of 50% of each
serotype was chosen for MLST analysis and evaluation of the presence and type
of the pilus islands (n=871). The initial collection had been previously
characterized regarding serotype distribution and antimicrobial susceptibility
to different classes of antibiotics.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:6.0pt'><b><span lang=EN-GB
style='font-size:8.0pt;mso-fareast-font-family:"Times New Roman";mso-bidi-font-family:
Arial;color:black;mso-ansi-language:EN-GB;mso-fareast-language:PT'>Results:</span></b><span
lang=EN-GB style='font-size:8.0pt;mso-fareast-font-family:"Times New Roman";
mso-bidi-font-family:Arial;color:black;mso-ansi-language:EN-GB;mso-fareast-language:
PT'> The genetic diversity was high with 206 different sequence types (STs)
detected (SID=0.971, CI95%: 0.967-0.976). Among these, 39 (4.5%) were new
alleles or combinations of alleles, while 587 (67.3%) were related to 29 of the
43 Pneumococcal Molecular Epidemiology Network (PMEN) recognized clones. The
different STs organized into 80 clonal complexes (CCs) according to goeBURST
(SID=0.948, CI95%: 0.942-0.953). There was a strong correlation between CC and
the vaccine serotype groups (AW=0.810, CI95%: 0.763-0.857), with the six most
prevalent CCs being mainly composed of isolates presenting vaccine serotypes
(95.5%) – CC156 (serotypes 14, 9V and 23F), CC191 (serotype 7F), CC180
(serotype 3), CC306 (serotype 1), CC62 (serotypes 8 and 11A) and CC230
(serotype 19A). Clonal expansion of previously circulating clones was the main
trigger of serotype replacement that occurred in adult IPD after the
introduction of the seven-valent pneumococcal conjugate vaccine (PCV7), while
capsular switching was infrequent and not related with vaccine use. However,
five isolates related to the PMEN clone Denmark<sup>14</sup>-230 expressed the
non-PCV13 serotype 24F. The overall proportion of isolates positive for any of
the pilus islands was small (31.9%) and declined gradually during the study
period (only 26.6% in 2011) due to the significant decline of serotype 1, which
is associated with pilus island 2. The reduction of IPD caused by PCV7
serotypes in the years following PCV7 implementation did not result in a
decline of antimicrobial resistance in part due to the selection of resistant
genotypes among serotypes 14 and 19A.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:6.0pt'><b><span lang=EN-GB
style='font-size:8.0pt;mso-fareast-font-family:"Times New Roman";mso-bidi-font-family:
Arial;color:black;mso-ansi-language:EN-GB;mso-fareast-language:PT'>Conclusion: </span></b><span
lang=EN-GB style='font-size:8.0pt;mso-fareast-font-family:"Times New Roman";
mso-bidi-font-family:Arial;color:black;mso-ansi-language:EN-GB;mso-fareast-language:
PT'>The dominant clonal complex causing invasive disease in Portugal still
expressed PCV7 serotypes. Significant changes in clonal composition are
expected with continued vaccine use, particularly following its adult
indication in 2012 and its introduction in the National Immunization Program
for children born in January 2015 onwards.<o:p></o:p></span></p>

<span lang=EN-GB style='font-size:8.0pt;line-height:115%;font-family:Arial;
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:EN-GB;
mso-fareast-language:PT;mso-bidi-language:AR-SA'><br clear=all
style='mso-special-character:line-break;page-break-before:always'>
</span>

<p class=MsoNormal align=left style='margin-bottom:10.0pt;text-align:left;
line-height:115%'><span lang=EN-GB style='font-size:8.0pt;line-height:115%;
mso-fareast-font-family:"Times New Roman";mso-bidi-font-family:Arial;
color:black;mso-ansi-language:EN-GB;mso-fareast-language:PT'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal><b style='mso-bidi-font-weight:normal'><span
style='mso-bidi-font-size:9.0pt;mso-fareast-font-family:"Times New Roman";
mso-bidi-font-family:Arial;mso-ansi-language:EN-US;mso-fareast-language:PT'>OP31
- Insight Into <i style='mso-bidi-font-style:normal'>Salmonella</i>
Epidemiology From Whole Genome Sequencing<span style='text-transform:uppercase'><o:p></o:p></span></span></b></p>

<p class=MsoNormal><u><span style='mso-bidi-font-size:9.0pt;mso-fareast-font-family:
"Times New Roman";mso-bidi-font-family:Arial;color:black;mso-ansi-language:
EN-US;mso-fareast-language:PT'>Philip Ashton</span></u><sup><span
style='mso-bidi-font-size:9.0pt;mso-fareast-font-family:"Times New Roman";
mso-bidi-font-family:Arial;color:black;mso-ansi-language:EN-US;mso-fareast-language:
PT'>1</span></sup><span style='mso-bidi-font-size:9.0pt;mso-fareast-font-family:
"Times New Roman";mso-bidi-font-family:Arial;color:black;mso-ansi-language:
EN-US;mso-fareast-language:PT'>; Satheesh Nair<sup>1</sup>; Elizabeth de Pinna<sup>1</sup>;
Richard Elson<sup>1</sup>; Philip Monk<sup>1</sup>; John Mair Jenkins<sup>1</sup>;
Sanch Kanagarajah<sup>1</sup>; Isidro Carrion<sup>1</sup>; Kathie Grant<sup>1</sup>;
Tim Dallman<sup>1</sup><o:p></o:p></span></p>

<p class=MsoNormal><i style='mso-bidi-font-style:normal'><sup><span
style='mso-bidi-font-size:9.0pt;mso-fareast-font-family:"Times New Roman";
mso-bidi-font-family:Arial;color:black;mso-ansi-language:EN-US;mso-fareast-language:
PT'>1</span></sup></i><i style='mso-bidi-font-style:normal'><span
style='mso-bidi-font-size:9.0pt;mso-fareast-font-family:"Times New Roman";
mso-bidi-font-family:Arial;color:black;mso-ansi-language:EN-US;mso-fareast-language:
PT'>Public Health England<o:p></o:p></span></i></p>

<p class=MsoNormal><i style='mso-bidi-font-style:normal'><span
style='mso-bidi-font-size:9.0pt;mso-fareast-font-family:"Times New Roman";
mso-bidi-font-family:Arial;color:black;mso-ansi-language:EN-US;mso-fareast-language:
PT'><o:p>&nbsp;</o:p></span></i></p>

<p class=MsoNormal style='margin-bottom:6.0pt'><span lang=EN-GB
style='font-size:8.0pt;mso-fareast-font-family:"Times New Roman";mso-bidi-font-family:
Arial;color:black;mso-ansi-language:EN-GB;mso-fareast-language:PT'>Public
Health England have been using whole genome sequencing (WGS) as the primary
test for <i>Salmonella</i> identification and typing since April 1<sup>st</sup>
2015. Since that time, there have been numerous outbreaks and incidents in
which WGS has been an invaluable tool. In this presentation, we will present
some of the most interesting examples alongside the methods we have developed
to identify clusters and communicate with diverse public health teams.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:6.0pt'><span lang=EN-GB
style='font-size:8.0pt;mso-fareast-font-family:"Times New Roman";mso-bidi-font-family:
Arial;color:black;mso-ansi-language:EN-GB;mso-fareast-language:PT'>Firstly,
there was a ‘slow-burn’ <i>Salmonella </i>Enteritidis Phage Type 8 cluster that
was identified using WGS. There were an average of 8 cases per month between
April 2014 and July 2015, which varied between 5% and 90% of the Enteritidis
PT8 received in each of those months. Without sequencing it would not be
possible to link these cases. On investigation, 81% of cases had contact with a
snake, compared with 0.5% of controls. Targeted investigations based on this identified
<i>Salmonella</i> Enteritidis from the same SNP cluster in mice fed to the
snakes.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:6.0pt'><span lang=EN-GB
style='font-size:8.0pt;mso-fareast-font-family:"Times New Roman";mso-bidi-font-family:
Arial;color:black;mso-ansi-language:EN-GB;mso-fareast-language:PT'>Secondly,
there was an outbreak of <i>Salmonella</i> 4, 5, 12:i:- sequence type 34 (aka
monophasic Typhimurium) associated with a restaurant that started as a typical
point source outbreak. However, there were further cases within the same SNP
cluster associated with the restaurant continuing for 30 weeks after the
original peak, despite stringent controls put in place by the operator. One of
the non-synonymous mutations that defines the outbreak was in the <i>mutS</i>
gene which encodes a DNA replication fidelity protein, we will present data on
the impact of this mutation on mutation rate.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:6.0pt'><span lang=EN-GB
style='font-size:8.0pt;mso-fareast-font-family:"Times New Roman";mso-bidi-font-family:
Arial;color:black;mso-ansi-language:EN-GB;mso-fareast-language:PT'>Finally, an
example of how valuable the accuracy of WGS can be in determining true links
between exposures and cases. A case was exposed at a restaurant which typed as <i>Salmonella</i>
Enteritidis PT 14b, an isolate was then isolated from chicken at the restaurant
which was phage type RDNC (reacts but does not conform). If you want to know
whether the chicken and the case were linked, you will have to come to the
talk!<o:p></o:p></span></p>

<span lang=EN-GB style='font-size:8.0pt;line-height:115%;font-family:Arial;
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:EN-GB;
mso-fareast-language:PT;mso-bidi-language:AR-SA'><br clear=all
style='mso-special-character:line-break;page-break-before:always'>
</span>

<p class=MsoNormal align=left style='margin-bottom:10.0pt;text-align:left;
line-height:115%'><span lang=EN-GB style='font-size:8.0pt;line-height:115%;
mso-fareast-font-family:"Times New Roman";mso-bidi-font-family:Arial;
color:black;mso-ansi-language:EN-GB;mso-fareast-language:PT'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal><b style='mso-bidi-font-weight:normal'><span
style='mso-bidi-font-size:9.0pt;mso-fareast-font-family:"Times New Roman";
mso-bidi-font-family:Arial;mso-ansi-language:EN-US;mso-fareast-language:PT'>OP32
- Next Generation Sequencing (NGS) Reveals Nosocomial Transmission Of
Livestock-Associated Methicillin Resistant <i style='mso-bidi-font-style:normal'>Staphylococcus
aureus</i> In Humans<span style='text-transform:uppercase'><o:p></o:p></span></span></b></p>

<p class=MsoNormal><u><span style='mso-bidi-font-size:9.0pt;mso-fareast-font-family:
"Times New Roman";mso-bidi-font-family:Arial;color:black;mso-ansi-language:
EN-US;mso-fareast-language:PT'>Thijs Bosch</span></u><sup><span
style='mso-bidi-font-size:9.0pt;mso-fareast-font-family:"Times New Roman";
mso-bidi-font-family:Arial;color:black;mso-ansi-language:EN-US;mso-fareast-language:
PT'>1</span></sup><span style='mso-bidi-font-size:9.0pt;mso-fareast-font-family:
"Times New Roman";mso-bidi-font-family:Arial;color:black;mso-ansi-language:
EN-US;mso-fareast-language:PT'>; Sandra Witteveen<sup>1</sup>; Martijn van Luit<sup>1</sup>;
Fabian Landman<sup>1</sup>; Anja Haenen<sup>1</sup>; Leo Schouls<sup>1</sup><o:p></o:p></span></p>

<p class=MsoNormal><i style='mso-bidi-font-style:normal'><sup><span
style='mso-bidi-font-size:9.0pt;mso-fareast-font-family:"Times New Roman";
mso-bidi-font-family:Arial;color:black;mso-ansi-language:EN-US;mso-fareast-language:
PT'>1</span></sup></i><i style='mso-bidi-font-style:normal'><span
style='mso-bidi-font-size:9.0pt;mso-fareast-font-family:"Times New Roman";
mso-bidi-font-family:Arial;color:black;mso-ansi-language:EN-US;mso-fareast-language:
PT'>National Institute for Public Health and the Environment<o:p></o:p></span></i></p>

<p class=MsoNormal><span style='mso-ansi-language:EN-US;mso-fareast-language:
PT'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:6.0pt'><b><span lang=EN-GB
style='font-size:8.0pt;mso-fareast-font-family:"Times New Roman";mso-bidi-font-family:
Arial;color:black;mso-ansi-language:EN-GB;mso-fareast-language:PT'>Background:</span></b><span
lang=EN-GB style='font-size:8.0pt;mso-fareast-font-family:"Times New Roman";
mso-bidi-font-family:Arial;color:black;mso-ansi-language:EN-GB;mso-fareast-language:
PT'> In the Netherlands, LA-MRSA CC398 isolated from humans is the predominant
MRSA clade among isolates submitted for typing in the Dutch MRSA surveillance.
Despite its high prevalence, the capability of LA-MRSA to transmit between
humans has been a subject of debate. In this study, we performed NGS on 126
LA-MRSA isolates to assess presumed transmission of LA-MRSA between humans in
Dutch healthcare settings.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:6.0pt'><b><span lang=EN-GB
style='font-size:8.0pt;mso-fareast-font-family:"Times New Roman";mso-bidi-font-family:
Arial;color:black;mso-ansi-language:EN-GB;mso-fareast-language:PT'>Methods:</span></b><span
lang=EN-GB style='font-size:8.0pt;mso-fareast-font-family:"Times New Roman";
mso-bidi-font-family:Arial;color:black;mso-ansi-language:EN-GB;mso-fareast-language:
PT'> To assess cut-off values in the NGS analysis, 62 LA-MRSA isolates from
well-documented transmission events were used. Forty isolates originated from
livestock veterinarians and their household members (HHM) and 12 isolates
originated from an outbreak in a Dutch nursing home. In addition, four
confirmed transmission events (<i>n</i>=8) in other Dutch healthcare facilities
were selected.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:6.0pt'><span lang=EN-GB
style='font-size:8.0pt;mso-fareast-font-family:"Times New Roman";mso-bidi-font-family:
Arial;color:black;mso-ansi-language:EN-GB;mso-fareast-language:PT'>Nosocomial
LA-MRSA transmission was studied using 12 LA-MRSA isolates from a presumed
outbreak in a Dutch hospital and 54 isolates from 23 presumed LA-MRSA
nosocomial transmission events. All isolates were sequenced using Illumina
technology.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:6.0pt'><span lang=EN-GB
style='font-size:8.0pt;mso-fareast-font-family:"Times New Roman";mso-bidi-font-family:
Arial;color:black;mso-ansi-language:EN-GB;mso-fareast-language:PT'>The SCC<i>mec</i>
region was identified and classified based on the currently known SCC<i>mec</i>-types.
For single nucleotide polymorphism (SNP) analysis, 11,439 SNPs were identified
based on the core genome of the Dutch LA-MRSA isolate RIVM-1295, previously
sequenced in our laboratory.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:6.0pt'><b><span lang=EN-GB
style='font-size:8.0pt;mso-fareast-font-family:"Times New Roman";mso-bidi-font-family:
Arial;color:black;mso-ansi-language:EN-GB;mso-fareast-language:PT'>Results:</span></b><span
lang=EN-GB style='font-size:8.0pt;mso-fareast-font-family:"Times New Roman";
mso-bidi-font-family:Arial;color:black;mso-ansi-language:EN-GB;mso-fareast-language:
PT'> SNP analysis revealed a maximum of 12 SNPs between isolates obtained from
veterinarians and their HHM. NGS of 12 isolates belonging to the outbreak in a
nursing home showed a maximum of 17 SNPs between the outbreak isolates (Figure
1). SCC<i>mec</i> of latter isolates revealed a unique type V (5C2&amp;5C)
variant, from which a 5.2kb fragment, including <i>tetK,</i> was deleted. All
four confirmed transmission events in Dutch healthcare facilities showed less
than 20 SNPs between the isolates and carried identical SCC<i>mec</i> types.
These results led to a cut-off value of ¡Ü20 SNPs for likely transmission,
whereas isolates yielding between 20-50 SNPs were regarded as possible
transmission events. Transmission was not likely when ¡Ý50 SNPs were identified
between isolates.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:6.0pt'><span lang=EN-GB
style='font-size:8.0pt;mso-fareast-font-family:"Times New Roman";mso-bidi-font-family:
Arial;color:black;mso-ansi-language:EN-GB;mso-fareast-language:PT'>Twelve
isolates of the presumed LA-MRSA outbreak in a Dutch hospital differed in 54
SNPs. This was caused by a single isolate taken from a different sampling site
of the index patient. However, another isolate obtained from the same index
patient only differed in eight SNPs from its nearest neighbor.<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:6.0pt'><span lang=EN-GB
style='font-size:8.0pt;mso-fareast-font-family:"Times New Roman";mso-bidi-font-family:
Arial;color:black;mso-ansi-language:EN-GB;mso-fareast-language:PT'>Of the
presumed transmission events, transmission likely occurred in 14 of the 23
events, with ¡Ü20 SNPs and identical SCC<i>mec</i> types between the isolates.
In seven presumed transmissions 20-50 SNPs were found and each pair carried the
same SCCmec region. In the remaining two events, transmission was highly
unlikely. In one event, isolates differed in 51 SNPs and carried different SCC<i>mec</i>
regions. In the remaining event (three isolates) transmission was likely in one
case (4 SNPs), but not in the other (124 SNPs, different SCC<i>mec</i>).<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:6.0pt'><b><span lang=EN-GB
style='font-size:8.0pt;mso-fareast-font-family:"Times New Roman";mso-bidi-font-family:
Arial;color:black;mso-ansi-language:EN-GB;mso-fareast-language:PT'>Conclusion:</span></b><span
lang=EN-GB style='font-size:8.0pt;mso-fareast-font-family:"Times New Roman";
mso-bidi-font-family:Arial;color:black;mso-ansi-language:EN-GB;mso-fareast-language:
PT'> Our study strongly supports the assumption that transmission of LA-MRSA in
Dutch healthcare settings does occur. NGS could confirm transmission in
well-documented events and indicated that transmission was unlikely in two
presumed transmissions. SCC<i>mec</i> proved to be a valuable addition to SNP
analysis, but other mobile genetic elements, such as plasmids, may provide
addition information on the transmission routes of this pathogen.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='margin-bottom:10.0pt;text-align:left;
line-height:115%'><span lang=EN-GB style='font-size:8.0pt;line-height:115%;
mso-fareast-font-family:"Times New Roman";mso-bidi-font-family:Arial;
color:black;mso-ansi-language:EN-GB;mso-fareast-language:PT'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal align=left style='margin-bottom:10.0pt;text-align:left;
line-height:115%'><span lang=EN-GB style='font-size:8.0pt;line-height:115%;
mso-fareast-font-family:"Times New Roman";mso-bidi-font-family:Arial;
color:black;mso-ansi-language:EN-GB;mso-fareast-language:PT'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:6.0pt'><span style='font-size:8.0pt;
mso-fareast-font-family:"Times New Roman";mso-bidi-font-family:Arial;
mso-ansi-language:EN-US;mso-no-proof:yes'><!--[if gte vml 1]><v:shapetype id="_x0000_t75"
 coordsize="21600,21600" o:spt="75" o:preferrelative="t" path="m@4@5l@4@11@9@11@9@5xe"
 filled="f" stroked="f">
 <v:stroke joinstyle="miter"/>
 <v:formulas>
  <v:f eqn="if lineDrawn pixelLineWidth 0"/>
  <v:f eqn="sum @0 1 0"/>
  <v:f eqn="sum 0 0 @1"/>
  <v:f eqn="prod @2 1 2"/>
  <v:f eqn="prod @3 21600 pixelWidth"/>
  <v:f eqn="prod @3 21600 pixelHeight"/>
  <v:f eqn="sum @0 0 1"/>
  <v:f eqn="prod @6 1 2"/>
  <v:f eqn="prod @7 21600 pixelWidth"/>
  <v:f eqn="sum @8 21600 0"/>
  <v:f eqn="prod @7 21600 pixelHeight"/>
  <v:f eqn="sum @10 21600 0"/>
 </v:formulas>
 <v:path o:extrusionok="f" gradientshapeok="t" o:connecttype="rect"/>
 <o:lock v:ext="edit" aspectratio="t"/>
</v:shapetype><v:shape id="Imagem_x0020_4" o:spid="_x0000_i1025" type="#_x0000_t75"
 alt="Description: https://www.eventgest.com/CLIENTES/veranatura/uploads/abstracts2/119imagem_2560108707_0.jpg"
 style='width:291pt;height:413pt;visibility:visible;mso-wrap-style:square'>
 <v:imagedata src="OP_S8_files/image001.jpg" o:title="//www.eventgest.com/CLIENTES/veranatura/uploads/abstracts2/119imagem_2560108707_0.jpg"/>
</v:shape><![endif]--><![if !vml]><img width=293 height=415
src="public/abstracts/Webpages/OP_S8_files/image002.png"
alt="Description: https://www.eventgest.com/CLIENTES/veranatura/uploads/abstracts2/119imagem_2560108707_0.jpg"
v:shapes="Imagem_x0020_4"><![endif]></span><span style='mso-ansi-language:EN-US;
mso-fareast-language:PT'><o:p></o:p></span></p>

<p class=MsoNormal><span lang=DE-CH><o:p>&nbsp;</o:p></span></p>

</div>

</body>

</html>
